Skip to main content
. 2011 May 14;2(2):241–249. doi: 10.1007/s13167-011-0082-1

Fig. 1.

Fig. 1

Image series of a 71 years old male patient suffering from a laryngeal cT4acN2bcM0 carcinoma (left) pre and intra therapy after receiving one cycle TPF + cetuximab (right); the patient was early evaluated as good responder